Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.

[1]  D. Shaw,et al.  Use of metered-dose inhaler electronic monitoring in a real-world asthma randomized controlled trial. , 2013, The journal of allergy and clinical immunology. In practice.

[2]  R. Beasley,et al.  Six-month in vitro validation of a metered-dose inhaler electronic monitoring device: implications for asthma clinical trial use. , 2012, Journal of Allergy and Clinical Immunology.

[3]  M. Weatherall,et al.  Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma. , 2010, The Journal of allergy and clinical immunology.

[4]  E. Bleecker,et al.  Subacute Lack of Asthma Control and Acute Asthma Exacerbation History as Predictors of Subsequent Acute Asthma Exacerbations: Evidence From Managed Care Data , 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.

[5]  F. Radner,et al.  Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials. , 2009, Respiratory medicine.

[6]  I. Pavord,et al.  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. , 2009, American journal of respiratory and critical care medicine.

[7]  T. Lasserson,et al.  Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children. , 2009, The Cochrane database of systematic reviews.

[8]  Martyn R Partridge,et al.  British Guideline on the Management of Asthma , 2008, Thorax.

[9]  A. Morice,et al.  Comparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler in adolescents and adults with asthma. , 2008, Pulmonary pharmacology & therapeutics.

[10]  F. Hampel,et al.  Early Bronchodilatory Effects of Budesonide/Formoterol pMDI Compared with Fluticasone/Salmeterol DPI and Albuterol pMDI: 2 Randomized Controlled Trials in Adults with Persistent Asthma Previously Treated with Inhaled Corticosteroids , 2008, The Journal of asthma : official journal of the Association for the Care of Asthma.

[11]  A. Tattersfield,et al.  Abstract Background , 2013 .

[12]  A. Morice,et al.  Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma , 2007, International journal of clinical practice.

[13]  P. Barnes,et al.  Scientific rationale for using a single inhaler for asthma control , 2007, European Respiratory Journal.

[14]  G. Rodrigo.  Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. , 2006, Chest.

[15]  K. Rabe,et al.  Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study , 2006, The Lancet.

[16]  P. Sly,et al.  In vitro evaluation of an asthma dosing device: the smart-inhaler. , 2006, Respiratory medicine.

[17]  P. Thompson,et al.  Formoterol Turbuhaler as reliever medication in patients with acute asthma , 2006, European Respiratory Journal.

[18]  P-C. Yang,et al.  Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. , 2006, Pulmonary pharmacology & therapeutics.

[19]  J. Bousquet,et al.  The effect of treatment with omalizumab, an anti‐IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma , 2005, Allergy.

[20]  H. Bisgaard,et al.  Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. , 2005, American journal of respiratory and critical care medicine.

[21]  P. Rothwell,et al.  External validity of randomised controlled trials: “To whom do the results of this trial apply?” , 2005, The Lancet.

[22]  R. Beasley,et al.  The use of the self-management plan system of care in adult asthma. , 2004, Primary care respiratory journal : journal of the General Practice Airways Group.

[23]  R. Pauwels,et al.  Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial , 2003, European Respiratory Journal.

[24]  R. Larsson,et al.  Relative therapeutic index between inhaled formoterol and salbutamol in asthma patients. , 2002, Respiratory medicine.

[25]  A. Sharafkhaneh,et al.  β-agonist intrinsic efficacy: Measurement and clinical significance , 2002 .

[26]  T. Lieu,et al.  Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma. , 2001, The European respiratory journal.

[27]  J. McNeil,et al.  Are asthma medications and management related to deaths from asthma? , 2001, American journal of respiratory and critical care medicine.

[28]  G H Guyatt,et al.  Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.

[29]  R. Dockhorn,et al.  Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study. , 1998, The Journal of allergy and clinical immunology.

[30]  W. Busse,et al.  Efficacy and safety of inhaled corticosteroids. New developments. , 1998, American journal of respiratory and critical care medicine.

[31]  S. Suissa,et al.  Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma. , 1994, The European respiratory journal.

[32]  N. Pearce,et al.  Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. , 1992, International journal of epidemiology.

[33]  Pierre Ernst,et al.  The Use of β-Agonists and the Risk of Death and near Death from Asthma , 1992 .

[34]  N. Pearce,et al.  The self-administration of inhaled beta agonist drugs during severe asthma. , 1990, The New Zealand medical journal.

[35]  N. Pearce,et al.  PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDY , 1989, The Lancet.

[36]  P. Stolley,et al.  Association between asthma mortality and isoproterenol aerosols: a review. , 1978, Preventive medicine.

[37]  J. Bradshaw,et al.  Medical audit , 1975, The Lancet.

[38]  F. Speizer,et al.  The circumstances preceding death from asthma in young people in 1968 to 1969. , 1971, British journal of diseases of the chest.